Trending...
- Financial Solutions Inc. Receives the 2020 Best of Sheridan Wyoming Award
- GT Molecular launches two highly sensitive tests for the dangerous UK Variant of SARS-CoV-2 (B.1.1.7)
- Spivey Hall Children's Choir Looks To 2021 Through The Lens of Langston Hughes Poetry
DENVER, Jan. 11, 2021 /PRNewswire/ -- SeaStar Medical, a medical technology company delivering novel therapeutic immunomodulating solutions to improve organ function, announced today it has appointed Rick Barnett and Dr. Allan J. Collins to its board of directors, effective January 8, 2021.
"We are excited and honored to welcome Rick and Allan as new independent directors to the SeaStar Medical board, " said Ray Chow, Chair of the Board of Directors of SeaStar Medical. "They join SeaStar Medical at an important time as we transition to commercializing our Selective Cytopheretic (SCD) therapeutic device. Rick and Allan bring significant and relevant expertise that will be valuable in executing the growth strategy."
Rick Barnett is the president and chief executive officer of Satellite Healthcare, the sixth-largest dialysis and kidney care company in the U.S. He also serves as the board chair of the National Kidney Foundation in the Northern California and Pacific Northwest regions. Prior to joining Satellite Healthcare, Mr. Barnett served as executive officer and senior vice president of VHA, Inc (now Vizient), a leading healthcare performance improvement company serving hospital organizations across the U.S. In this role, he was responsible for 120 hospitals. He also has served as the president and CEO of Mercy Medical Center, a 276-bed regional tertiary and trauma center in Redding, California.
More on Colorado Desk
Allan J. Collins, M.D., FACP is currently senior chief scientist and past chief medical officer of NxStage Fresenius Medical Care North America. Fresenius is the world's leading provider of products and services for people with chronic kidney failure. He also serves as an Emeritus Professor of Medicine at the University of Minnesota, where he has also taught since 1980. Dr. Collins is actively involved with several professional societies, including the National Kidney Foundation, where he served as president from 2006-2008, the International Society of Nephrology Commission for the Global Advancement of Nephrology, European Renal Association/European Dialysis and Transplant Association, and the NKF Kidney Dialysis Outcomes Quality Initiative. He was given the highest clinical honor, the Belding Scribner Award, from the American Society of Nephrology in 2015. He was the Director of the NIH's United States Renal Data System from 1999-2014. He is a renowned expert on kidney disease and dialysis, with more than 300 journal publications and invited to 450 presentations internationally.
"The addition of Allan and Rick to the SeaStar Medical Board of Directors is another important step in advancing our business and clinical strategy. Allan's deep insight in hemofiltration functionality is a huge asset. His overall experience will be a guide to our long-term clinical development for the SCD both in the acute and chronic populations," said Chow. "Rick's business experience with hospital systems and the cardio-renal space will be instrumental in executing our commercialization plans."
More on Colorado Desk
About SeaStar Medical
Denver-based SeaStar Medical is a privately held medical technology company that has redefined how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs through novel solutions and services. SeaStar Medical's focus is on removing pro-inflammatory mediators, known as cytokines, or transforming key immune system messengers from pro-inflammatory to reparative physiology. SeaStar Medical's next-generation technologies rely on science and innovation to build upon existing purification technologies to provide life-saving solutions to critically ill patients. For more information visit seastarmedical.com or visit us on LinkedIn.
SOURCE SeaStar Medical
"We are excited and honored to welcome Rick and Allan as new independent directors to the SeaStar Medical board, " said Ray Chow, Chair of the Board of Directors of SeaStar Medical. "They join SeaStar Medical at an important time as we transition to commercializing our Selective Cytopheretic (SCD) therapeutic device. Rick and Allan bring significant and relevant expertise that will be valuable in executing the growth strategy."
Rick Barnett is the president and chief executive officer of Satellite Healthcare, the sixth-largest dialysis and kidney care company in the U.S. He also serves as the board chair of the National Kidney Foundation in the Northern California and Pacific Northwest regions. Prior to joining Satellite Healthcare, Mr. Barnett served as executive officer and senior vice president of VHA, Inc (now Vizient), a leading healthcare performance improvement company serving hospital organizations across the U.S. In this role, he was responsible for 120 hospitals. He also has served as the president and CEO of Mercy Medical Center, a 276-bed regional tertiary and trauma center in Redding, California.
More on Colorado Desk
- Qurate Retail Announces Semi-Annual Interest Payment and Excess Regular Cash Dividend Amount Distribution on 3.5% Senior Exchangeable Debentures Due 2031
- Colorado Springs: Mayor Suthers Selects New Fire Chief
- AUA College of Medicine Establishes Admissions Agreement with Mississippi Valley State University
- AlloSource's ProChondrix CR, Cryopreserved Osteochondral Allograft, To Be Featured At The British Patellofemoral Society Meeting
- Dollyhood Records Signs Distribution Deal With Sony!
Allan J. Collins, M.D., FACP is currently senior chief scientist and past chief medical officer of NxStage Fresenius Medical Care North America. Fresenius is the world's leading provider of products and services for people with chronic kidney failure. He also serves as an Emeritus Professor of Medicine at the University of Minnesota, where he has also taught since 1980. Dr. Collins is actively involved with several professional societies, including the National Kidney Foundation, where he served as president from 2006-2008, the International Society of Nephrology Commission for the Global Advancement of Nephrology, European Renal Association/European Dialysis and Transplant Association, and the NKF Kidney Dialysis Outcomes Quality Initiative. He was given the highest clinical honor, the Belding Scribner Award, from the American Society of Nephrology in 2015. He was the Director of the NIH's United States Renal Data System from 1999-2014. He is a renowned expert on kidney disease and dialysis, with more than 300 journal publications and invited to 450 presentations internationally.
"The addition of Allan and Rick to the SeaStar Medical Board of Directors is another important step in advancing our business and clinical strategy. Allan's deep insight in hemofiltration functionality is a huge asset. His overall experience will be a guide to our long-term clinical development for the SCD both in the acute and chronic populations," said Chow. "Rick's business experience with hospital systems and the cardio-renal space will be instrumental in executing our commercialization plans."
More on Colorado Desk
- West Coast Recording Artist, Composer and Actor, Blue Ragg$ Releases New Music & Theatrical Video
- Swaggerty's Receives Highest Possible Grade from BRC Food Safety Auditors for 8th Consecutive Year
- Be an Example, Get the Covid Shot
- Fathom Celebrates Black History Month With First Film Series This February
- Former CEO & Founder of Five Star Custom Foods, Acquired by Cargill, Joins CEO Coaching International
About SeaStar Medical
Denver-based SeaStar Medical is a privately held medical technology company that has redefined how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs through novel solutions and services. SeaStar Medical's focus is on removing pro-inflammatory mediators, known as cytokines, or transforming key immune system messengers from pro-inflammatory to reparative physiology. SeaStar Medical's next-generation technologies rely on science and innovation to build upon existing purification technologies to provide life-saving solutions to critically ill patients. For more information visit seastarmedical.com or visit us on LinkedIn.
SOURCE SeaStar Medical
Filed Under: Business
0 Comments
Latest on Colorado Desk
- DocBuddy Selected as Allscripts App of the Month Centralizes access to medical records on the go
- AI.Reverie Awarded $950 Million IDIQ Contract for U.S. Air Force Advanced Battle Management System (ABMS)
- Updated ASI Book Helps Association Executives Improve Organizational Performance Now and Post-COVID
- BellRock Brands Confirms Previous 2020 Financial Guidance of Merged Companies; Issues 2021 Guidance
- MBK Senior Living Ranks 7th On Fortune Best Workplaces For Aging Services List
- Colorado Springs: Behind the Springs Podcast: COS@150
- droneselite.com Your Team of Trusted RC Drone Professionals
- Hemp extraction company Zelios Colorado is now Gemini Extraction & Refinement Solutions
- Fifth Gen Media announces Darlene Pope as Chairman of the Advisory Council
- MGL Partners Selects Rainbow Housing as Service Provider for Colorado Affordable Housing Community
- Phinge To Launch Netverse, a Rewards-Based Alternative to Apple and Google Using Innovative Proprietary Technology and Patented Mobile Devices
- GT Molecular launches two highly sensitive tests for the dangerous UK Variant of SARS-CoV-2 (B.1.1.7)
- Spivey Hall Children's Choir Looks To 2021 Through The Lens of Langston Hughes Poetry
- MedAware Systems launches Comprehensive Structural Heart Device Surveillance for Reported Events
- ADDING and REPLACING Neat Capital Secures $22.5 Million In Series B Funding Round
- Wohler releases AoIP & Analog options for their iVAM1-1
- Lalit Jalan, visionary business leader, joins as 3Lines India Chairman
- Guidehouse Insights Report Shows Annual Revenue for Utility Customer Experience and Management Technologies Analytics Is Expected to Near $700 Million by 2029
- While Supplies Last: Thermal Transfer Label Sale
- The Business Consultant behind The First Black-owned BP